Ma W. et. al.: Enhanced Antitumor Immunity of a Globo H-Based Vaccine Enabled by the Combination Adjuvants of 3D-MPL and QS-21.

Angew Chem Int Ed Engl, 2024 Dec 16:e202418948. PMID: 39679641.

The study presents a novel adjuvant-assisted Globo H-based anticancer vaccine platform. The article advocates for the efficacy of a combination QS-21/3D-MPL adjuvant for improving the immunological response in Globo H-based cancer vaccine.

The article outlines that the Globo H-CRM197 conjugate, when adjuvanted with QS-21 and 3D-MPL, generates strong IgG2a and IgG3 responses and Th1 cellular immunity, which are crucial for effective anticancer responses.

The study demonstrates that the synergistic effect of 3D-MPL and QS-21 provides a more potent immunological response than using each adjuvant alone or other single-adjuvant formulations.

Click here to access the full scientific paper.